Since NAA10 and its auxiliary subunit NAA15 are overexpressed in certain cancers, protein degraders targeting NAA10 or NAA15 offer a promising strategy to eliminate NAA10 in tumors where its overexpression drives tumorigenesis. Here, NAA10 is linked to cancer.